These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 519455)

  • 21. Further clinical trials with oxamniquine (UK 4271), a new anti-schistosomal agent.
    da Silva LC; Sette H; Chamone DA; Sáez-Alquezar A; Punskas JA; Raia S
    Rev Inst Med Trop Sao Paulo; 1975; 17(5):307-11. PubMed ID: 1198006
    [No Abstract]   [Full Text] [Related]  

  • 22. Dose-finding trials of oral oxamniquine in Rhodesia.
    de V Clarke V; Blair DM; Weber MC; Garnett PA
    S Afr Med J; 1976 Oct; 50(46):1867-71. PubMed ID: 996687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni.
    Haese WH; Bueding E
    J Pharmacol Exp Ther; 1976 Jun; 197(3):703-13. PubMed ID: 180276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Schistosoma mansoni infection with oxamniquine in Riyadh, Saudi Arabia.
    Al-Aska AK
    Trop Med Parasitol; 1985 Dec; 36(4):213-4. PubMed ID: 3937212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seizures and electroencephalograph changes associated with oxamniquine therapy.
    Keystone JS
    Am J Trop Med Hyg; 1978 Mar; 27(2 Pt 1):360-2. PubMed ID: 646029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxamniquine for treating Schistosoma mansoni infection in Sudan.
    Omer AH
    Br Med J; 1978 Jul; 2(6131):163-5. PubMed ID: 678831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic-protective activity of oral oxamniquine against Schistosoma mansoni infection in hamsters.
    Girgis NI; Mansour NS; Kahlil SB
    East Afr Med J; 1979 Sep; 56(9):428-30. PubMed ID: 520260
    [No Abstract]   [Full Text] [Related]  

  • 28. [Efficacy of oxamniquine in Schistosoma mansoni bilharziasis in Madagascar in a hospital milieu].
    Queinnec J; Moyroud J
    Arch Inst Pasteur Madagascar; 1981; 48(1):143-9. PubMed ID: 7342891
    [No Abstract]   [Full Text] [Related]  

  • 29. [Oxamniquine in the treatment of Schistosoma mansoni infection].
    Kapend'a K; Odio W; Toko AL; Vandepitte J; Kayembe NN; Wane J
    Ann Soc Belg Med Trop; 1982; 62(3):213-9. PubMed ID: 7181541
    [No Abstract]   [Full Text] [Related]  

  • 30. Field experiences with oral oxamniquine in the treatment of schistosomiasis mansoni.
    Coura JR; Argento CA; Conceição MJ; Lewis EM; dos Santos ML; Magalhães P
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):77-84, 195-202. PubMed ID: 7455514
    [No Abstract]   [Full Text] [Related]  

  • 31. Oxamniquine treatment in experimental schistosomiasis mansoni. Biological, morphological and pathological changes induced by divided doses.
    Mikhail EG; Sabet S; Mahran SG; Gaber AA; Soliman AA; Zaki IE; Tadros MB
    J Egypt Soc Parasitol; 1981 Jun; 11(1):33-49. PubMed ID: 7299160
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of oxamniquine in the treatment of S. mansoni infection among Sudanese patients.
    Ibrahim AM
    East Afr Med J; 1980 Aug; 57(8):566-73. PubMed ID: 7408738
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of oxamniquine in treatment of S. mansoni in a closed community in Egypt and the concomitant administration of both metrifonate and oxamniquine in mixed infections.
    Saif M; Gaber A; Hassanein YS; Khameis S
    J Egypt Med Assoc; 1978; 61(5-6):427-31. PubMed ID: 400362
    [No Abstract]   [Full Text] [Related]  

  • 34. Preliminary clinical trial of oral oxamniquine in the treatment of Schistosoma mansoni in Ethiopia.
    Ayele T
    East Afr Med J; 1984 Aug; 61(8):632-6. PubMed ID: 6399027
    [No Abstract]   [Full Text] [Related]  

  • 35. Spinal cord disease due to Schistosoma mansoni successfully treated with oxamniquine.
    Efthimiou J; Denning D
    Br Med J (Clin Res Ed); 1984 May; 288(6427):1343-4. PubMed ID: 6424851
    [No Abstract]   [Full Text] [Related]  

  • 36. Oxamniquine (Vansil) in the treatment of schistosomiasis in Rhodesia.
    de Clarke V
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):28-31, 144-7. PubMed ID: 7455506
    [No Abstract]   [Full Text] [Related]  

  • 37. Schistosomiasis control in Peri-Peri (Minas Gerais, Brazil) by repeated clinical treatment and molluscicide application.
    Katz N; Rocha RS; Pereira JP
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):85-93, 203-11. PubMed ID: 7455515
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum levels and efficacy of oxamniquine in patients with Schistosomiasis mansoni following administration of a therapeutic dose.
    da Silva LC; Sette Júnior H; Christo C; Sette PC; Kaye B
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):58-64, 175-81. PubMed ID: 7455511
    [No Abstract]   [Full Text] [Related]  

  • 39. Schistosoma mansoni treatment with oral oxamniquine in Zambia.
    Gupta KK
    East Afr Med J; 1984 Aug; 61(8):641-4. PubMed ID: 6399028
    [No Abstract]   [Full Text] [Related]  

  • 40. Oxamniquine (UK 4271) In the treatment of vesical schistosomiasis in Western Nigeria.
    Kale OO; Lucas AO
    Rev Inst Med Trop Sao Paulo; 1978; 20(1):55-63. PubMed ID: 349665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.